GI, Pancreas

Markets Indications include

• Crohn’s disease
• Irritable Bowel Syndrome
• Mucositis / Halitosis treatment
• Severe Acute Pancreatits

Recent assignments

• Serve as US agent for an ODD submission to FDA for a drug to treat gut inflammatory disease
• Review non-clinical development plan
• Design a non-clinical development plan for a borderline product to be marketed in India
• IND development
• Provide pre-marketing PV services in France for a clinical trial